Compare CRVS & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVS | CSR |
|---|---|---|
| Founded | 2014 | 1970 |
| Country | United States | United States |
| Employees | N/A | 349 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 931.7M |
| IPO Year | 2016 | N/A |
| Metric | CRVS | CSR |
|---|---|---|
| Price | $14.89 | $55.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | $30.17 | ★ $69.80 |
| AVG Volume (30 Days) | ★ 1.4M | 164.2K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | ★ 48.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.24 |
| Revenue Next Year | N/A | $2.72 |
| P/E Ratio | ★ N/A | $62.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.96 | $52.76 |
| 52 Week High | $26.95 | $69.61 |
| Indicator | CRVS | CSR |
|---|---|---|
| Relative Strength Index (RSI) | 57.88 | 34.56 |
| Support Level | $14.24 | $54.50 |
| Resistance Level | $16.85 | $58.13 |
| Average True Range (ATR) | 0.81 | 1.39 |
| MACD | 0.12 | 0.20 |
| Stochastic Oscillator | 60.08 | 13.04 |
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.